Clinical trial
Pompe Disease Registry Protocol
NCT00231400 · Genzyme, a Sanofi Company, Industry · Recruiting
Key facts
| NCT number | NCT00231400 |
|---|---|
| Title | Pompe Disease Registry Protocol |
| Official title | Pompe Disease Registry |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Recruiting |
| Study type | Observational [Patient Registry] |
| Conditions | Glycogen Storage Disease Type II, Pompe Disease |
| Enrollment | 2,000 |
| Start date | Sep 15, 2004 |
| Primary completion | Jan 31, 2034 |
| Completion | Jan 31, 2034 |
| First posted | Oct 4, 2005 |
| Last update posted | Jan 14, 2026 |
| Countries | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark and 32 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: